Anti-il12p35 antibodies and their uses
CO20260012636A2Pending Publication Date: 2026-09-09D2M BIOTHERAPEUTICS LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CO20260012636
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-31
- Filing Date
- 2026-08-28
- Publication Date
- 2026-09-09
Abstract
This description relates to anti-IL12p35 antibodies (interleukin-12 alpha subunit), antigen-binding fragments, and their uses. In some modalities, the anti-IL12p35 antibodies or antigen-binding fragments described herein may be used to treat systemic sclerosis (SSc), primary biliary cholangitis (PBC), systemic lupus erythematosus (SLE), and / or Sjögren's syndrome (SjS).
Need to check novelty before this filing date? Find Prior Art